Patents by Inventor Benjamin Biro Mugrage

Benjamin Biro Mugrage has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Phenylacetic Acid Derivatives
    Publication number: 20140058129
    Abstract: Compounds of formula (I) pharmaceutically acceptable salts thereof; and pharmaceutically acceptable esters thereof; which are useful for the treatment of COX-2 dependent disorders.
    Type: Application
    Filed: August 22, 2013
    Publication date: February 27, 2014
    Applicant: NOVARTIS AG
    Inventors: Lauren G. MONOVICH, Benjamin Biro Mugrage
  • Phenylacetic acid derivatives
    Patent number: 8586782
    Abstract: Compounds of formula (I) pharmaceutically acceptable salts thereof; and pharmaceutically acceptable esters thereof; which are useful for the treatment of COX-2 dependent disorders.
    Type: Grant
    Filed: September 12, 2012
    Date of Patent: November 19, 2013
    Assignee: Novartis AG
    Inventors: Lauren G. Monovich, Benjamin Biro Mugrage
  • Phenylacetic acid derivatives
    Patent number: 8362294
    Abstract: Compounds of formula (I) pharmaceutically acceptable salts thereof, and pharmaceutically acceptable esters thereof; which are useful for the treatment of COX-2 dependent disorders.
    Type: Grant
    Filed: June 25, 2007
    Date of Patent: January 29, 2013
    Assignee: Novartis AG
    Inventors: Lauren G. Monovich, Benjamin Biro Mugrage
  • Phenylacetic Acid Derivatives
    Publication number: 20130012585
    Abstract: Compounds of formula (I) pharmaceutically acceptable salts thereof; and pharmaceutically acceptable esters thereof; which are useful for the treatment of COX-2 dependent disorders.
    Type: Application
    Filed: September 12, 2012
    Publication date: January 10, 2013
    Inventors: Lauren G. Monovich, Benjamin Biro Mugrage
  • Phenylacetic Acid Derivatives
    Publication number: 20090209648
    Abstract: Compounds of formula (I) pharmaceutically acceptable salts thereof, and pharmaceutically acceptable esters thereof; which are useful for the treatment of COX-2 dependent disorders.
    Type: Application
    Filed: June 25, 2007
    Publication date: August 20, 2009
    Inventors: Lauren G. Monovich, Benjamin Biro Mugrage